×
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.17 (-0.34%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.17 (-0.34%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.17 (-0.34%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
S&P 500   3,772.19 (-1.39%)
DOW   30,567.49 (-1.70%)
QQQ   281.17 (-0.34%)
AAPL   139.34 (+0.30%)
MSFT   257.51 (-0.80%)
META   163.30 (+2.04%)
GOOGL   2,194.79 (+0.92%)
AMZN   111.55 (+1.82%)
TSLA   672.99 (-1.29%)
NVDA   146.19 (+0.66%)
NIO   21.54 (+0.84%)
BABA   115.39 (-0.53%)
AMD   73.85 (+0.24%)
MU   54.98 (+2.48%)
CGC   2.67 (-4.98%)
T   20.87 (-2.06%)
GE   61.03 (-3.95%)
F   10.92 (-3.53%)
DIS   94.67 (-1.53%)
AMC   12.78 (-5.54%)
PFE   50.51 (-3.44%)
PYPL   72.47 (+1.50%)
NFLX   181.38 (+0.79%)
OTCMKTS:BABYF

Else Nutrition Stock Forecast, Price & News

$0.50
+0.02 (+4.73%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$0.45
$0.51
50-Day Range
$0.48
$1.11
52-Week Range
$0.45
$2.92
Volume
193,500 shs
Average Volume
153,320 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Else Nutrition MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
300.0% Upside
$2.00 Price Target
Short Interest
Bearish
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.20mentions of Else Nutrition in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.41 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive BABYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Else Nutrition and its competitors with MarketBeat's FREE daily newsletter.

Else Nutrition logo

About Else Nutrition (OTCMKTS:BABYF) Stock

Else Nutrition Holdings Inc. engages in the development, production, and sale of food and nutrition products for infants, toddlers, children, and adults in North America and Israel. It offers baby snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby formula products; toddler, children, and adult nutrition products; and complementary food products. The company also offers its products through online. Else Nutrition Holdings Inc. is headquartered in Tel Aviv-Yafo, Israel.

BABYF Stock News Headlines

IIROC Trade Resumption - BABY
Else Nutrition Holdings reports Q4 results
See More Headlines

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
OTCMKTS:BABYF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+300.0%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














Else Nutrition Frequently Asked Questions

Should I buy or sell Else Nutrition stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Else Nutrition in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Else Nutrition stock.
View analyst ratings for Else Nutrition
or view top-rated stocks.

What is Else Nutrition's stock price forecast for 2022?

1 brokerages have issued 1 year price objectives for Else Nutrition's stock. Their BABYF stock forecasts range from $2.00 to $2.00. On average, they predict Else Nutrition's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 300.0% from the stock's current price.
View analysts' price targets for Else Nutrition
or view top-rated stocks among Wall Street analysts.

How has Else Nutrition's stock performed in 2022?

Else Nutrition's stock was trading at $0.90 at the start of the year. Since then, BABYF shares have decreased by 44.4% and is now trading at $0.50.
View the best growth stocks for 2022 here
.

Who are Else Nutrition's key executives?

Else Nutrition's management team includes the following people:
  • Ms. Hamutal Yitzhak, Co-Founder, Chairman & CEO (Age 54, Pay $231.97k)
  • Mr. Uriel Kesler, Co-Founder, COO & Director (Age 62, Pay $231.97k)
  • Mr. Shay Shamir, CFO & Corp. Sec.
  • Mr. Michael Azar, Co-Founder & CTO
  • Mr. Reuben Halevi, VP of Sales Operations (Age 65)
  • Ms. Liliana Frimerman, Head of Bookkeeping & Payroll
  • Ms. Chelsie Hodge, Director of Corp. Relations

What is Else Nutrition's stock symbol?

Else Nutrition trades on the OTCMKTS under the ticker symbol "BABYF."

How do I buy shares of Else Nutrition?

Shares of BABYF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Else Nutrition's stock price today?

One share of BABYF stock can currently be purchased for approximately $0.50.

How can I contact Else Nutrition?

Else Nutrition's mailing address is 4 Raul Wallenberg Street, Tel Aviv, 6971904. The official website for Else Nutrition is www.elsenutrition.com. The company can be reached via phone at 888 879 3573.

This page (OTCMKTS:BABYF) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.